...
首页> 外文期刊>Biotechnology Progress >A Perfusion Culture System Using a Stirred Ceramic Membrane Reactor for Hyperproduction of IgG_(2a) Monoclonal Antibody by Hybridoma Cells
【24h】

A Perfusion Culture System Using a Stirred Ceramic Membrane Reactor for Hyperproduction of IgG_(2a) Monoclonal Antibody by Hybridoma Cells

机译:使用搅拌陶瓷膜反应器的灌注培养系统,用于杂交瘤细胞超量生产IgG_(2a)单克隆抗体

获取原文
获取原文并翻译 | 示例
           

摘要

A novel perfusion culture system for efficient production of IgG_(2a) monoclonal antibody (mAb) by hybridoma cells was developed.A ceramic membrane module was constructed and used as a cell retention device installed in a conventional stirred-tank reactor during the perfusion culture.Furthermore,the significance of the control strategy of perfusion rate (volume of fresh medium/working volume of reactor/day,vvd) was investigated.With the highest increasing rate (AD,wd per day,vvdd) of perfusion rate,the maximal viable cell density of 3.5 x 10~7 cells/mL was obtained within 6 days without any limitation and the cell viability was maintained above 95%.At lower AD's,the cell growth became limited.Under nutrient-limited condition,the specific cell growth rate (mu) was regulated by AD.During the nonlimited growth phase,the specific mAb production rate (q_(mAb)) remained constant at 0.26+-0.02 pg/cell-h in all runs.During the cell growth-limited phase,q_(mAb) was regulated by AD within the range of 0.25-0.65 wdd.Under optimal conditions,q_(mAb) of 0.80 and 2.15 pg/cellcentre doth was obtained during the growth-limited phase and stationary phase,respectively.The overall productivity and yield were 690 mg/L-day and 340 mg/L-medium,respectively.This study demonstrated that this novel perfusion culture system for suspension mammalian cells can support high cell density and efficient mAb production and that AD is an important control parameter to regulate and achieve high mAb production.
机译:开发了一种新型的可通过杂交瘤细胞高效产生IgG_(2a)单克隆抗体(mAb)的灌注培养系统,构建了陶瓷膜组件并将其用作灌注培养过程中安装在常规搅拌罐反应器中的细胞保留装置。此外,研究了灌注速率控制策略的意义(新鲜培养基的体积/反应器的工作量/天,vvd)。以最高的灌注速率(AD,wd每天,vvdd),最大可行在6天内无任何限制地获得3.5×10〜7细胞/ mL的细胞密度,并且细胞存活率保持在95%以上。在较低的AD下,细胞生长受到限制。在营养受限的条件下,比细胞生长速率(μ)由AD调节。在非限制性生长阶段,在所有运行中特定的mAb产生速率(q_(mAb))在所有运行中均保持恒定在0.26 + -0.02 pg / cell-h。 (mAb)受RA内AD调节nge为0.25-0.65 wdd。在最佳条件下,生长受限期和固定期的q_(mAb)分别为0.80和2.15 pg / cellcentre。总生产力和产量为690 mg / L-day和这项研究表明,这种新型的悬浮哺乳动物细胞灌注培养系统可以支持高细胞密度和有效的mAb产生,而AD是调节和实现高mAb产生的重要控制参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号